Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Oral administration of the omega-3 fatty acid eicosapentaenoic acid (EPA), as the free fatty acid (FFA), leads to EPA incorporation into, and reduced growth of, experimental colorectal cancer liver metastases (CRCLM). DESIGN: We performed a Phase II double-blind, randomised, placebo-controlled trial of EPA-FFA 2 g daily in patients undergoing liver resection surgery for CRCLM. The patients took EPA-FFA (n=43) or placebo (n=45) prior to surgery. The primary end-point was the CRCLM Ki67 proliferation index (PI). Secondary end-points included safety and tolerability of EPA-FFA, tumour fatty acid content and CD31-positive vascularity. We also analysed overall survival (OS) and disease-free survival (DFS). RESULTS: The median (range) duration of EPA-FFA treatment was 30 (12-65) days. Treatment groups were well matched with no significant difference in disease burden at surgery or preoperative chemotherapy. EPA-FFA treatment was well tolerated with no excess of postoperative complications. Tumour tissue from EPA-FFA-treated patients demonstrated a 40% increase in EPA content (p=0.0008), no difference in Ki67 PI, but reduced vascularity in 'EPA-naïve' individuals (p=0.075). EPA-FFA also demonstrated antiangiogenic activity in vitro. In the first 18 months after CRCLM resection, EPA-FFA-treated individuals obtained OS benefit compared with placebo, although early CRC recurrence rates were similar. CONCLUSIONS: EPA-FFA therapy is safe and well tolerated in patients with advanced CRC undergoing liver surgery. EPA-FFA may have antiangiogenic properties. Remarkably, limited preoperative treatment may provide postoperative OS benefit. Phase III clinical evaluation of prolonged EPA-FFA treatment in CRCLM patients is warranted. TRIAL IDENTIFIER: ClinicalTrials.gov NCT01070355.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Mechanisms of Action of (n-3) Fatty Acids,
Calder, P. C. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.155259 · Cited by 871
Altered eicosanoid levels in human colon cancer.
Rigas, B., Goldman, I. S., & Levine, L. (1993) · PubMed · Cited by 569
Incorporation and Clearance of Omega-3 Fatty Acids in Erythrocyte Membranes and Plasma Phospholipids
Cao, J., Schwichtenberg, K. A., Hanson, N. Q., & Tsai, M. Y. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.072322 · Cited by 351
Bioavailability of long-chain omega-3 fatty acids
Schuchardt, J. P., & Hahn, A. (2013) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.03.010 · Cited by 344
Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer
Cockbain, A. J., Toogood, G. J., & Hull, M. A. (2012) · Gut · doi:10.1136/gut.2010.233718 · Cited by 305
Self-citationDietary sources of omega 3 fatty acids: public health risks and benefits
Tur, J. A., Bibiloni, M. M., Sureda, A., & Pons, A. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001456 · Cited by 283
Bougnoux, P., Hajjaji, N., Ferrasson, M. N., Giraudeau, B., Couet, C., & Le Floch, O. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605441 · Cited by 264
Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis
West, N. J., Clark, S. K., Phillips, R. K. S., Hutchinson, J. M., Leicester, R. J., Belluzzi, A., & Hull, M. A. (2010) · Gut · doi:10.1136/gut.2009.200642 · Cited by 244
Self-citationThe effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential
Spencer, L., Mann, C., Metcalfe, M., Webb, M., Pollard, C., Spencer, D., Berry, D., Steward, W., & Dennison, A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.026 · Cited by 243
Cited by
Watson, H., Mitra, S., Croden, F. C., Taylor, M., Wood, H. M., Perry, S. L., Spencer, J. A., Quirke, P., Toogood, G. J., Lawton, C. L., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314968 · Cited by 506
Self-citationEnvironmental Factors, Gut Microbiota, and Colorectal Cancer Prevention
Song, M., & Chan, A. T. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.012 · Cited by 355
Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy
D’Eliseo, D., & Velotti, F. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020015 · Cited by 303
Fiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197
Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
Pantziarka, P. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.521 · Cited by 165
Metadata
- Authors
- Cockbain, A. J., Volpato, M., Race, A. D., Munarini, A., Fazio, C., Belluzzi, A., Loadman, P. M., Toogood, G. J., & Hull, M. A.
- Affiliations
- Leeds Teaching Hospitals NHS Trust (GB)
- Section of Molecular Gastroenterology, Leeds Institute of Biomedical & Clinical Sciences, St James's University Hospital, Leeds, UK
- University of Bradford (GB)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- St James's University Hospital (GB)
- Corresponding author
- Hull, Mark A
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2014-01-27
- Volume
- 63
- Issue
- 11
- Pages
- 1760-1768
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2156826845
- Cited by
- 115
- References
- 31
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 12 · 2021: 8 · 2020: 10 · 2019: 7 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 8 · 2014: 3
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- Bradford Scholars (University of Bradford) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Cancer Research UK
- National Institute for Health and Care Research
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- eicosapentaenoic acid, omega-3 fatty acids, colorectal liver metastases, hepatectomy, antiangiogenic activity, tumor vascularity, Ki-67 proliferation index, overall survival, disease-free survival, tolerability
- MeSH terms
- Adult, Aged, Aged, 80 and over, Chromatography, Liquid, Double-Blind Method, Female, Humans, Immunohistochemistry, Liver Neoplasms, Male, Middle Aged, Eicosapentaenoic Acid, Colorectal Neoplasms, Anticarcinogenic Agents, Platelet Endothelial Cell Adhesion Molecule-1, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid. https://app.cochat.ai/papers/10.1136/gutjnl-2013-306445
- The paper
- Cockbain, A. J., Volpato, M., Race, A. D., Munarini, A., Fazio, C., Belluzzi, A., Loadman, P. M., Toogood, G. J., & Hull, M. A. (2014). Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid. Gut. https://doi.org/10.1136/gutjnl-2013-306445
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.